BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 21059119)

  • 1. Leukotriene modifiers for asthma treatment.
    Montuschi P; Peters-Golden ML
    Clin Exp Allergy; 2010 Dec; 40(12):1732-41. PubMed ID: 21059119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological modulation of the leukotriene pathway in allergic airway disease.
    Montuschi P; Sala A; Dahlén SE; Folco G
    Drug Discov Today; 2007 May; 12(9-10):404-12. PubMed ID: 17467577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Leukotrienes and Leukotriene Modifiers in Asthma.
    Montuschi P
    Pharmaceuticals (Basel); 2010 Jun; 3(6):1792-1811. PubMed ID: 27713330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukotrienes, antileukotrienes and asthma.
    Montuschi P
    Mini Rev Med Chem; 2008 Jun; 8(7):647-56. PubMed ID: 18537720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review on leukotrienes and their receptors with reference to asthma.
    Singh RK; Tandon R; Dastidar SG; Ray A
    J Asthma; 2013 Nov; 50(9):922-31. PubMed ID: 23859232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
    Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
    Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of leukotrienes in the pathophysiology of inflammatory disorders: is there a case for revisiting leukotrienes as therapeutic targets?
    Sharma JN; Mohammed LA
    Inflammopharmacology; 2006 Mar; 14(1-2):10-6. PubMed ID: 16835707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New developments in asthma therapy: how do individual leukotriene antagonists work?].
    Wagener M
    Praxis (Bern 1994); 1998 Feb; 87(8):271-5. PubMed ID: 9542455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukotriene modifiers in pediatric asthma management.
    Bisgaard H
    Pediatrics; 2001 Feb; 107(2):381-90. PubMed ID: 11158473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antileukotrienes in the therapy of bronchial asthma].
    Riccioni G; Della Vecchia R; Menna V; Lambo MS; Di Ilio C; D'Orazio N
    Recenti Prog Med; 2003 Nov; 94(11):509-15. PubMed ID: 14679921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone.
    Murai A; Abe M; Hayashi Y; Sakata N; Katsuragi T; Tanaka K
    J Pharmacol Exp Ther; 2005 Feb; 312(2):432-40. PubMed ID: 15470084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic modulation of allergic airways disease with leukotriene receptor antagonists.
    Currie GP; Srivastava P; Dempsey OJ; Lee DK
    QJM; 2005 Mar; 98(3):171-82. PubMed ID: 15728398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of leukotrienes in the management of asthma: biology and clinical therapy.
    Leff AR
    Annu Rev Med; 2001; 52():1-14. PubMed ID: 11160764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors and role of leukotrienes in asthma.
    Devillier P; Baccard N; Advenier C
    Pharmacol Res; 1999 Jul; 40(1):3-13. PubMed ID: 10378985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Status of leukotrienes in the pathophysiology of asthma. Necessity for antileukotrienes treatment].
    Fal AM; Kopeć A
    Pneumonol Alergol Pol; 2010; 78(1):68-73. PubMed ID: 20162521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling.
    Holgate ST; Peters-Golden M; Panettieri RA; Henderson WR
    J Allergy Clin Immunol; 2003 Jan; 111(1 Suppl):S18-34; discussion S34-6. PubMed ID: 12532084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukotriene receptor antagonists--risks and benefits for use in paediatric asthma.
    Spahr JE; Krawiec ME
    Expert Opin Drug Saf; 2004 May; 3(3):173-85. PubMed ID: 15155146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antileukotriene agents for the treatment of lung disease.
    Scott JP; Peters-Golden M
    Am J Respir Crit Care Med; 2013 Sep; 188(5):538-44. PubMed ID: 23822826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cysteinyl leukotrienes and their receptors: molecular and functional characteristics.
    Singh RK; Gupta S; Dastidar S; Ray A
    Pharmacology; 2010; 85(6):336-49. PubMed ID: 20516735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Leukotriene modifiers].
    Minoguchi K; Adachi M
    Nihon Rinsho; 2001 Oct; 59(10):1979-85. PubMed ID: 11676142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.